Modification of in vitro immune lymphocyte-target cell interaction by some biologically active drugs.
D000818:Animals; D002470:Cell Survival; D002738:Chloroquine; D002852:Chromatography, Ion Exchange; D003601:Cytotoxicity Tests, Immunologic; D006493:Heparin; D007109:Immunity; D007700:Kinetics; D008214:Lymphocytes / Q000166:cytology / Q000276:immunology*; D008264:Macrophages; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D009439:Neuraminidase; D010740:Phospholipases; D011135:Polysaccharides, Bacterial; D011239:Prednisolone; D011402:Pronase; D011817:Rabbits / Q000276:immunology; D012509:Sarcoma / Q000276:immunology; D013056:Spectrophotometry, Ultraviolet; D013194:Staining and Labeling; D013997:Time Factors; D014343:Trypan Blue; D014357:Trypsin; D014462:Ultrafiltration
D011135:Polysaccharides, Bacterial; D002738:Chloroquine; D006493:Heparin; D011239:Prednisolone; D010740:Phospholipases; D009439:Neuraminidase; D014357:Trypsin; D011402:Pronase; D014343:Trypan Blue